The technology provides the industry with many opportunities, but it must also navigate a complex regulatory landscape.
Robert Paradiso
Advertisement
Articles by Robert Paradiso
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novartis Investors Share Concerns Over M&A Strategy: Report
2
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
3
The Agentic AI Revolution in Biopharma
4
Pharmaceutical Executive Daily: Novartis Shareholders Raise Concerns over M&A Strategy
5